The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...

On , Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.

A large number of Australian biotechs are waiting for US FDA product approval – or are on the cusp of ... Read More The post ...

A bipartisan bill would add optional anti-choking devices in Kentucky’s schools. But experts urge caution as they’re not ...

Here’s a recap of our 10 most-read F&B stories from January 2025, including top trends, emerging categories and regulations expected to drive the market this year, China tariff adjustments, ...

While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective ...

With egg prices returning to sky-high levels, there's a major opportunity for plant-based and fermentation-derived ...